शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

BSEEIKO LIFESCIENCES LIMITED· Chemicals & PetrochemicalsLowNeutral
Announced Mon, 2 Nov, 2026 · 19:55 IST

Board meeting set for 5 November 2026 results

Revenue growth above 20%EBITDA margin compressionNegative operating cash flowResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.4%Reaction day
₹50.74
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+2.1% vs market
Specialty Chemicals peers, median of 99sector+0.0%+2.4% vs sector

On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 2.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.4+0.3+2.1+0.0+2.4
Next day
+0.4+2.4-2.0+1.0-0.6
2d
+2.4+3.6-1.2+2.0+0.4
3d
+1.2pendingpending+1.1+0.1
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 99Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The filing provides no consolidated figures for the latest quarter ended 30 September 2026 or its year-earlier comparison. The board will consider unaudited consolidated and standalone results for the quarter and half-year ended 30 September 2026 on 5 November 2026. The trading window remains closed until 48 hours after results are declared.

Likely market impact

Results are pending, so shareholders cannot yet assess earnings, cash flow or financial strength. The stock may react when the results are published.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹17.72 Cr₹11.67 Cr+51.8%
Operating profit₹1.82 Cr₹1.41 Cr+28.9%
Profit after tax₹1.56 Cr₹1.28 Cr+21.7%
EBITDA margin12.6%15.1%−2.5 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.